Neither clinical status nor overall mortality was improved in COVID-19 patients with severe pneumonia treated with convalescent plasma in a randomized trial, researchers in Argentina said. At 30 days in the 333-patient trial, the convalescent plasma group ...
from Google Alert - health https://ift.tt/3753sSH
via IFTTT
0 comments:
Post a Comment